Compare NAC & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NAC | LMAT |
|---|---|---|
| Founded | 1998 | 1983 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.1B |
| IPO Year | 1998 | 2006 |
| Metric | NAC | LMAT |
|---|---|---|
| Price | $11.72 | $98.93 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $105.80 |
| AVG Volume (30 Days) | ★ 335.6K | 278.7K |
| Earning Date | 01-01-0001 | 05-05-2026 |
| Dividend Yield | ★ 4.33% | 0.93% |
| EPS Growth | N/A | ★ 30.57 |
| EPS | N/A | ★ 0.68 |
| Revenue | N/A | ★ $249,602,000.00 |
| Revenue This Year | N/A | $14.21 |
| Revenue Next Year | N/A | $8.88 |
| P/E Ratio | ★ N/A | $140.57 |
| Revenue Growth | N/A | ★ 13.53 |
| 52 Week Low | $10.94 | $79.01 |
| 52 Week High | $12.25 | $118.01 |
| Indicator | NAC | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 26.23 | 51.12 |
| Support Level | $11.64 | $95.47 |
| Resistance Level | $12.04 | $114.98 |
| Average True Range (ATR) | 0.08 | 3.63 |
| MACD | -0.04 | -0.47 |
| Stochastic Oscillator | 0.05 | 43.93 |
Nuveen California Quality Municipal Income Fund is a closed-end fixed income mutual fund that prominently invests in tax-exempt municipal bonds from California. The Fund's primary investment objective is current income exempt from both regular federal income taxes and Arizona individual income taxes. Its portfolio mainly includes investment-grade municipal securities of California. The fund targets various sectors such as healthcare, utilities, transportation, and consumer staples.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.